Here are three things to know:
1. The patent application has cleared internal review and is now awaiting patent issuance.
2. The patent encompasses treatment methods of compression or contusion spinal cord injuries with a variety of biodegradable or bioabsorbable polymeric implants including the Neuro-Spinal Scaffold.
3. InVivo is the excusive licensee of this intellectual property through a license with Boston Children’s Hospital and Cambridge-based Massachusetts Institute of Technology.
More articles on devices:
MiMedx files lawsuit against Osiris Therapeutics — 4 things to know
Blue Belt Technologies co-founder wins outstanding entrepreneur award: 5 things to know
Novastep, Vivex Biomedical partner: 4 points
